<DOC>
	<DOC>NCT00548600</DOC>
	<brief_summary>The specific objective of this study is to compare the relative efficacy of the combination of a temporary iridium implant plus external beam irradiation versus standard external beam irradiation alone in patients with Stage B2 and C prostatic carcinoma. Benefit will be assessed in terms of local recurrence, survival, and toxicity.</brief_summary>
	<brief_title>Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>All patients must have histologically proven adenocarcinoma of the prostate The primary tumour should be staged clinically B2 or C as classified by A.J.C. Staging System Patients requiring transurethral prostatectomy (TURP) prior to diagnosis Presence of metastases identified by bone scan, chest xray or CT scan of the abdomen and pelvis, or staging lymphadenectomy Karnofsky performance status less than 80 Inadequate laboratory results: i.e. Hb &lt; 12 gm/litre, WBC &lt; 3.5 x 10 per litre, platelets &lt; 100 x 10/litre, urea &gt; 13 mmol/litre, creatinine &gt; 220 mmol/litre Unfit for surgery for other medical reasons Age above 75 years Failure to provide written informed consent</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>Iridium</keyword>
	<keyword>Implant</keyword>
	<keyword>Radiotherapy</keyword>
</DOC>